pali cardiology revision: heart failure

19
PALi Cardiology Revision: Heart Failure Lucille Ramani [email protected]

Upload: dalia

Post on 23-Mar-2016

43 views

Category:

Documents


0 download

DESCRIPTION

PALi Cardiology Revision: Heart Failure. Lucille Ramani [email protected]. Heart Failure. Definition. “a complex of signs and symptoms that occurs when the heart fails to pump adequate CO”. Epidemiology. Prevalence: 3-20 per 1000 5% emergency admissions - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: PALi  Cardiology Revision: Heart Failure

PALi Cardiology Revision:Heart FailureLucille [email protected]

Page 2: PALi  Cardiology Revision: Heart Failure

“a complex of signs and symptoms that occurs when the heart fails to pump adequate CO”

Heart Failure

Definition

Epidemiology• Prevalence: 3-20 per 1000• 5% emergency admissions• by 50% in the next 25 years • 50% dead by 5 years • Mainly a disease of the older population (>65 years)

Page 3: PALi  Cardiology Revision: Heart Failure

Aetiology

Cause Specific ExamplesCardiovascular disease IHD; cardiomyopathies; HTN; myocarditis;

valvular heart disease; congenital heart diseases Pulmonary disease Pulmonary HTN; pulmonary valve stenosis; PE; chronic

pulmonary disease; neuromuscular disease

Toxins Heroin; alcohol; cocaine; amphetamines; lead; arsenic; cobalt; phosphorus

Infection Bacterial; fungal; viral (HIV); Borrelia burgdorferi (Lyme disease); sepsis

Electrolyte imbalance calcium, phosphate, potassium, sodiumEndocrine disorders DM; thyroid disease; hypoparathyroidism;

phaeochromocytoma; acromegaly

Systemic collagen vascular diseases

SLE; RA; systemic sclerosis; polyarteritis nodosa; Reiter’s syndrome

Drug-induced Adriamycin; cyclophosphamide; sulphonamidesNutritional deficiencies Thiamine; selenium; L-carnitine

Pregnancy Peripartum cardiomyopathy

Page 4: PALi  Cardiology Revision: Heart Failure

• Aetiology:– Chronic pulmonary disease cor pulmonale – Left-sided heart failure – Patent ductus arteriosus– Isolated right-sided cardiomyopathy– Tricuspid valve disease

• RV pressure backward failure systemic venous congestion

Right Heart Failure (RHF)

Page 5: PALi  Cardiology Revision: Heart Failure

• Symptoms– Fatigue – Dyspnoea– Anorexia, nausea– Nocturia

• Signs– JVP– Smooth, tender hepatomegaly – Ascites– Pitting oedema (sacral, ankle)– Hypotension – Cyanosis, cool peripheries

RHF: Clinical Features

Page 6: PALi  Cardiology Revision: Heart Failure

• Ischaemic heart disease• Chronic systemic HTN• Cardiomyopathy (usually dilated)• Mitral / Aortic valve disease

– Mitral regurgitation: volume overload ( preload )– Aortic stenosis: pressure overload ( afterload)

• Consequence = pulmonary congestion

LHF: Aetiology

Page 7: PALi  Cardiology Revision: Heart Failure

• Symptoms– Fatigue – Dyspnoea: exertional; orthopnoea; paroxysmal nocturnal – Cough ± frothy pink sputum; haemoptysis

• Signs – Few, but prominent at late stage – Weight loss; muscle wasting – Cardiomegaly – Pulmonary oedema (creps)– Hypotension; cool peripheries – S3 and tachycardia: triple gallop rhythm

LHF: Clinical Features

Page 8: PALi  Cardiology Revision: Heart Failure

• Compensatory mechanisms become overwhelmed and thus pathological (cardiac decompensation)

• Key concepts:– CO is a function of preload and afterload– Preload: end-diastolic wall stress (initial stretching of myocytes)– Afterload: the resistance against which the heart has to pump– Frank-Starling mechanism: change in SV in response to change in preload– in preload via Rx is beneficial – in workload and symptoms arising from venous congestion

Pathophysiology

Page 9: PALi  Cardiology Revision: Heart Failure

1. filling pressures to maintain SV2. Dilation: increased wall tension ischaemia

3. Hypertrophy to balance pressure overload4. Sinus tachycardia5. Neurohormonal mechanisms

• Activation of RAAS- systemic vascular resistance- Aldosterone release (Na+ and water retention)- ADH release (water retention)

• Sympathetic activity ( catecholamines)- HR, force of contraction and peripheral vasoconstriction

Compensatory Changes

Page 10: PALi  Cardiology Revision: Heart Failure

Diagnosis of HF (European Society of Cardiology Guidelines)Essential Features1. Symptoms and signs of heart failure (e.g. SOB, fatigue, ankle oedema)2. Objective evidence of cardiac dysfunction (at rest)

Non-essential Features: in cases where there is diagnostic doubt 3. Response to treatment directed towards heart failure

Diagnosis

• Bloods; cardiac enzymes/markers • BNP (>100pg/mL = 95% specificity and 98% sensitivity • ECG• Transthoracic doppler ECHO: EF<0.45

Page 11: PALi  Cardiology Revision: Heart Failure

)

• Alveolar oedema (“Bat’s wings”)• Kerley B lines (interstitial oedema)• Cardiomegaly • Dilated prominent upper lobe vessels • Pleural Effusions

• LV dysfunction dilation of pulmonary vessels leakage of fluid into interstitium pleural effusion alveolar oedema (pulmonary oedema)

Chest X-ray Findings

Page 12: PALi  Cardiology Revision: Heart Failure

• Aims:– Treat cause, e.g. valve disease– Treat exacerbating factors, e.g. anaemia, HTN– Relieve S+S – Augment survival

• General Measures:– Smoking cessation – Salt reduction and fluid restriction if severe– Maintenance of optimal weight and nutrition – Vaccinations: pneumoccocal (once only) and annual influenza – Assess for depression – Monitor: functional capacity, fluid status, cardiac rhythm

Management

Page 13: PALi  Cardiology Revision: Heart Failure

• Diuretics– Routinely loop diuretics, e.g. Furosemide 40mg/24h po (increase prn)– Can add spironolactone or metolazone

• ACEi – Long-acting, e.g. lisinopril 10mg/24h po– Start with small dose and increase every 2 weeks until at target (30-40mg)– Warn patients of side effects: hypotension (esp after first dose- advise to lie

down); dry cough; hyperkalaemia; taste disturbance– Check U+E and creatinine before starting and with each titration

Pharmacological Rx

Page 14: PALi  Cardiology Revision: Heart Failure

• Beta-blockers– Initiate after ACEi and diuretic – Start low, go slow e.g. carvedilol 3.125mg/bd 25-50mg/bd (at least 2 week

increments)

• Angiotensin-II receptor antagonists – Alternative if intolerant of ACEi

• Digoxin – Use if diuretics, ACEi or BB do not control symptoms or if in AF – 0.125mg-0.24mg/24h po– Monitor U+E and maintain potassium at 4-5mmol/L

Pharmacological Rx

Page 15: PALi  Cardiology Revision: Heart Failure

• Most commonly occurs in context of acute MI extensive loss of ventricular muscle

– Also: PE, cardiac tamponade, rupture of IV septum (producing VSD), AF

• Clinical presentation:– Acute worsening (decompensation) of chronic HF – Acute pulmonary oedema: respiratory distress, crackles, pink frothy sputum– Cardiogenic shock: hypotension, tachycardia, oliguria

• Investigations:– CXR– ECG; consider ECHO and BNP – U+E; cardiac markers; ABGs

Acute HF

Page 16: PALi  Cardiology Revision: Heart Failure

• Different to chronic; Rx before Ix• Sit pt up + high-flow O2 (100% if no lung disease)• IV access and ECG (Rx any arrhythmia, e.g. AF)• Diamorphine 2.5-5mg IV slowly • Furosemide 40-80mg IV slowly • GTN spray 2 puffs sublingual then infusion of

isosorbide dinitrate 2-10mg/h• If pt worsening- first get help, then:

– Further dose of furosemide – Consider ventilation or increasing nitrate infusion

Acute HF Management

Page 17: PALi  Cardiology Revision: Heart Failure

MEQ 1.2 A 78 year old man had a large anterior myocardial infarction 3 years ago. Initially he made a good recovery although he has required to take a diuretic for ankle swelling since. In the last 2 months he has become short of breath on exertion. You suspect he has developed left ventricular failure

Marks

(a) Give 2 additional symptoms which would support this diagnosis 2

(b) You arrange for a chest x-ray. Give 4 features which would support the diagnosis of left ventricular failure

4

(c) Give 2 neurohumoral mechanisms which may be activated in heart failure 1

(d) If starting this patient on an ACE Inhibitor give 3 precautions you would take 3

MEQ Past Paper

Page 18: PALi  Cardiology Revision: Heart Failure

• What are the possible causes for deterioration in HF? (3)

• Immediate treatment of acute HF and how you would administer this? (3)

Further Questions

Page 19: PALi  Cardiology Revision: Heart Failure

Any Questions?

Thank-you!